Zika Virus Disease (ECDC/EU Case Definition)
Table of Contents
Authors: European Centre for Disease Prevention and Control (ECDC)
Location: European Union
Purpose #
EU/ECDC case definition for Zika virus disease surveillance, per Commission Implementing Decision (EU) 2018/945: clinical criteria (rash), laboratory criteria for confirmed and probable cases, and epidemiological criteria (travel/residence in a transmission area or sexual contact with an exposed/confirmed person).
The definition #
Clinical criteria: A person presenting with a rash.
Laboratory criteria for confirmed case (at least one of the following):
- Detection of Zika virus nucleic acid in a clinical specimen
- Detection of Zika virus antigen in a clinical specimen
- Isolation of Zika virus from a clinical specimen
- Detection of Zika virus specific IgM antibodies in serum sample(s) AND confirmation by neutralisation test
- Seroconversion or four-fold increase in the titre of Zika specific antibodies in paired serum samples
Laboratory criteria for probable case: Detection of Zika specific IgM antibodies in a serum sample.
Epidemiological criteria (at least one of the following):
- History of travel to, or residence in an area with documented on-going transmission of Zika virus, within the two-week period prior to the onset of symptoms
- Sexual contact with a person recently exposed to or confirmed with Zika virus infection
Case classification: A. Possible case: not applicable B. Probable case: a person meeting the clinical and epidemiological criteria, with a probable-level laboratory result C. Confirmed case: a person meeting the laboratory criteria for case confirmation
Machine-readable definition #
The definition is available in JSON format following the Open Syndrome v1.0 specification:
{
"$schema": "https://w3id.org/opensyndrome/v1/schema.json",
"@context": "https://opensyndrome.org/schema/v1/context.jsonld",
"authors": [],
"category": "probable",
"definition_type": "case_definition",
"description": "EU/ECDC case definition for Zika virus disease surveillance, per Commission Implementing Decision (EU) 2018/945: clinical criteria (rash), laboratory criteria for confirmed and probable cases, and epidemiological criteria (travel/residence in a transmission area or sexual contact with an exposed/confirmed person).",
"human_readable_definition": "Clinical criteria:\nA person presenting with a rash.\n\nLaboratory criteria for confirmed case (at least one of the following):\n- Detection of Zika virus nucleic acid in a clinical specimen\n- Detection of Zika virus antigen in a clinical specimen\n- Isolation of Zika virus from a clinical specimen\n- Detection of Zika virus specific IgM antibodies in serum sample(s) AND confirmation by neutralisation test\n- Seroconversion or four-fold increase in the titre of Zika specific antibodies in paired serum samples\n\nLaboratory criteria for probable case:\nDetection of Zika specific IgM antibodies in a serum sample.\n\nEpidemiological criteria (at least one of the following):\n- History of travel to, or residence in an area with documented on-going transmission of Zika virus, within the two-week period prior to the onset of symptoms\n- Sexual contact with a person recently exposed to or confirmed with Zika virus infection\n\nCase classification:\nA. Possible case: not applicable\nB. Probable case: a person meeting the clinical and epidemiological criteria, with a probable-level laboratory result\nC. Confirmed case: a person meeting the laboratory criteria for case confirmation",
"inclusion_criteria": [
{
"logical_operator": "OR",
"name": "Zika virus disease case classification (probable or confirmed)",
"type": "criterion",
"values": [
{
"logical_operator": "AND",
"name": "Confirmed case (laboratory criteria for case confirmation)",
"type": "criterion",
"values": [
{
"logical_operator": "OR",
"name": "Laboratory criteria for confirmed case",
"type": "criterion",
"values": [
{
"name": "Detection of Zika virus nucleic acid in a clinical specimen",
"type": "diagnostic_test"
},
{
"name": "Detection of Zika virus antigen in a clinical specimen",
"type": "diagnostic_test"
},
{
"name": "Isolation of Zika virus from a clinical specimen",
"type": "diagnostic_test"
},
{
"logical_operator": "AND",
"name": "Zika-specific IgM antibodies detected, confirmed by neutralisation test",
"type": "criterion",
"values": [
{
"name": "Zika virus specific IgM antibodies detected in serum sample(s)",
"type": "diagnostic_test"
},
{
"name": "Confirmation by neutralisation test",
"type": "diagnostic_test"
}
]
},
{
"name": "Seroconversion or four-fold increase in the titre of Zika specific antibodies in paired serum samples",
"type": "diagnostic_test"
}
]
}
]
},
{
"logical_operator": "AND",
"name": "Probable case (clinical, epidemiological and probable-level laboratory criteria)",
"type": "criterion",
"values": [
{
"name": "Rash",
"type": "symptom"
},
{
"logical_operator": "OR",
"name": "Epidemiological criteria",
"type": "criterion",
"values": [
{
"description": "History of travel to, or residence in an area with documented on-going transmission of Zika virus, within the two-week period prior to the onset of symptoms",
"name": "Travel or residence in transmission area",
"type": "epidemiological_history"
},
{
"description": "Sexual contact with a person recently exposed to or confirmed with Zika virus infection",
"name": "Sexual contact with exposed or confirmed person",
"type": "epidemiological_history"
}
]
},
{
"description": "Probable-level laboratory criterion (does not require confirmation by neutralisation test)",
"name": "Zika specific IgM antibodies detected in a serum sample",
"type": "diagnostic_test"
}
]
}
]
}
],
"keywords": [
"Zika",
"arbovirus",
"flavivirus",
"ECDC",
"European Union",
"case definition"
],
"language": "English",
"location": "European Union",
"notes": [],
"open_syndrome_version": "1.0.0",
"organization": "European Centre for Disease Prevention and Control (ECDC)",
"published_at": "2026-09-09T14:00:00Z",
"published_by": [
"Open Syndrome Initiative"
],
"published_in": "https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32018D0945\u0026from=EN#page=53",
"references": [
{
"citation": "Commission Implementing Decision (EU) 2018/945 of 22 June 2018 on the communicable diseases and related special health issues to be covered by epidemiological surveillance as well as relevant case definitions, Annex II.",
"url": "https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32018D0945\u0026from=EN#page=53"
},
{
"citation": "European Centre for Disease Prevention and Control (ECDC). Case definition for surveillance of Zika virus infection.",
"url": "https://www.ecdc.europa.eu/en/zika-virus-infection/surveillance-and-disease-data/case-definition"
}
],
"scope": "specific",
"status": "draft",
"surveillance_system_type": "EU epidemiological surveillance under Commission Implementing Decision (EU) 2018/945",
"target_public_health_threats": [
"Zika virus disease",
"Zika virus infection"
],
"title": "Zika Virus Disease (ECDC/EU Case Definition)",
"version": "1.0.0"
}
Using the Definition #
Healthcare organizations can implement this definition through:
- Direct integration with surveillance systems
- API endpoints for real-time validation
- Manual case verification processes
Next Steps #
We encourage:
- Clinical feedback on the definition criteria
- Technical feedback on the implementation format
- Suggestions for additional symptoms or signs
- Reports of implementation experiences
Get Involved #
We welcome contributions and feedback from the community.